By Col Teresa M. Skojac, MD, MPH, USAF, MC; and Mark D. Ackerman, PhD
Col. Skojac is chief of the medical staff at Malcolm Grow Medical Clinics and Surgery Center at Joint Base Andrews in Maryland and in May 2014 will join the staff at the Tallahassee VA Outpatient Clinic in Florida as the chief of medicine. Dr. Ackerman is the health behavior coordinator and director of the Nicotine Addiction Treatment Program at the Atlanta VA Medical Center, and an adjunct assistant professor in the Department of Psychiatry and Behavioral Sciences at the Emory University School of Medicine, both in Atlanta, Georgia.
This study was a first step in examining barriers to treatment. Although the sample size was small, it is representative and useful in providing a framework from which to improve access to tobacco cessation programs as well as encourage utilization of alternative resources.
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
